| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в лютому 1999 (uk)
- im Februar 1999 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en febreru de 1999 (ast)
- artikull shkencor i botuar më 01 shkurt 1999 (sq)
- scientific article published on 01 February 1999 (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - Mandelli F
- Martino P
- Leoni P
- Specchia G
- Del Favero A
- Micozzi A
- Menichetti F
- Raimondi R
- Bucaneve G
- Barbabietola G
- Caiozzo A
- Pagańo L
|
| rdfs:label
| - Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche (en)
- Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche (nl)
- Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche (sq)
|
| skos:prefLabel
| - Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche (en)
- Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche (nl)
- Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche (sq)
|
| name
| - Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche (en)
- Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche (nl)
- Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche (sq)
|
| author
| |
| author
| |
| title
| |
| title
| - Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| is about
of | |
| is cites work
of | - Infections following hematopoietic stem cell transplantation
- Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents
- Infectious complications of febrile leukopenia
- Interventions for preventing oral candidiasis for patients with cancer receiving treatment
- Aspergillosis. Pathogenesis, clinical manifestations, and therapy
- Fungal infections in nontransplant patients with hematologic malignancies
- Interventions for preventing oral candidiasis for patients with cancer receiving treatment
- Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
- Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome
- Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
- Clinical pharmacology of antifungal compounds
- Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
- Epidemiology and Prevention of Invasive Aspergillosis
- Infectious morbidity in critically ill patients with cancer
- Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients
- Incidence and prognostic value of respiratory events in acute leukemia.
- In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida
- Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients
- Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint
- Therapy for fungal infections in leukemia
- Aspergillus infections in transplant recipients
- Pharmacology of itraconazole
- Use of prophylactic antifungals in the immunocompromised host.
- Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials
- Current management of fungal infections.
- Emerging Issues in Nosocomial Fungal Infections
- A systematic review of oral fungal infections in patients receiving cancer therapy.
- The current management of infectious diseases in the liver transplant recipient
- Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice
- Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
- The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies.
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)